Purdue Pharma is the first drug manufacturer to implement a new
software program that allows firms to order all Schedule I & II
controlled substance purchases on a single electronic form -
potentially saving up to 90 per cent...
Murex Pharmaceuticals has licensed Ariadne's software solution,
which is to play a vital role in the visualisation and analysis of
biological pathways and gene regulation networks for cancer
therapeutics development.
Researchers have taken a special interest in mechanisms they have
identified as an explanation for the causes of Parkinson's disease,
which they say, may facilitate research aimed at finding novel
medical treatments and other...
The insulin market is set to explode over the next five years as
uptake of insulin therapy is likely to increase with sufferers
benefiting from heightened awareness and knowledge as well as the
influx of affordable, innovative product...
Partnerships in drug delivery need to fairly reflect the risk all
parties take but there must also be a champion to drive the project
forward, according to Pfizer's director of drug delivery.
A new report compiled in the wake of the drug trial scandal, which
left six men fighting for their lives, has re-iterated the call for
scientists to proceed with extreme caution when testing such drugs
in the future.
GlaxoSmithKline (GSK) said it has developed a vaccine against the
H5N1 bird flu strain that can trigger an immune response at a much
lower dose than other vaccines in development.
Genentech and Inotek have entered into a strategic alliance in
which they will concentrate on the discovery, development and
commercialisation of PARP inhibitors for cancer - a class of drug
that has demonstrated high efficacy in...
Quintiles has announced the opening of a new biostatistics unit
that it claims will help pharma firms cut the time and cost of drug
development through the "adaptive design" of clinical trials.
Avalon Pharmaceuticals and ChemDiv have revealed details on a
collaboration in which the two companies are to engage in drug
discovery in the oncology sector focusing on small molecules as a
basis for therapeutic development.
Locus Pharmaceuticals is to initiate Phase I trials of a novel
anticancer drug that could prove effective against drug resistant
tumours after the small molecule cleared the 30-day review period
by the FDA for its Investigational...
Aegis Therapeutics has unveiled a new formulation technology
employing non-toxic excipients that maintain the physical stability
and physiological activity of protein and peptide therapeutics
while reducing immunogenicity.
Mass spectroscopy as an analytical laboratory technique proved it's
worth again recently after Cerno Bioscience and Wyeth
Pharmaceuticals jointly produced a paper that demonstrates the high
mass accuracy that can be achieved...
In a controversial move, the US Food and Drug Administration (FDA)
has given the final nod of approval to pharma companies who want to
add colourful pearlescent pigments to their drugs to give them that
"special something."
Anderson Packaging has bought 12 acres of land next to its existing
US headquarters and now plans to build another new facility to
expand its contract pharma packaging capacity by 20 per cent.
Outourcing-Pharma focus on: FDA clinical trial initiatives
The US Food and Drug Administration (FDA) has announced a series of
new policy and regulatory developments to modernise the way it
monitors clinical trials and bioresearch.
Celera Genomics announces its new test that is used for genotyping
of the hepatitis C virus (HCV) has obtained regulatory approval for
commercial sale in Europe, signifying the first real-time test for
genotyping the HCV virus to...
UK and Chinese R&D firms are this week being urged to band
together to develop alternatives to the practice of using
endangered animal parts to feed the vast traditional Chinese
medicine industry.
Omnia Biologics has sealed a deal to help the Aeras Global TB
Vaccine Foundation in its quest to make quantities of a new TB
Vaccine that will "fulfil all the needs of the developing
world."
Israeli biopharma firm Kamada will manufacture transferrin for an
undisclosed European pharma firm embarking on the first ever
clinical trials of a drug that includes the substance.
Chugai Pharmaceutical has decided to manufacture a modified version
of Roche's Tamiflu (oseltamivir) in a dry syrup formulation which
can be stored at room temperature after the bottle is opened,
allowing for more storage capacity...
A new white paper has been made available to laboratories
worldwide, which aims to minimise the risk of infection through
focused biosafety reviews and further reinforce the required level
of infection control.
A new concept to develop a more accurate method for rapidly
screening chemical compounds has been unveiled, which the
researchers say will significantly aid in identifying leads for
drug development and discovery.
The US Food and Drug Administration (FDA) has outlined a series of
imminent changes to the way it evaluates clinical trials in an
attempt to clamp down on fraud.
The pharmaceutical and life sciences industries are flushed with
quality IT services, with eight companies that have a specialist
life science/pharmaceutical focus being featured in the top 20 of
the first-ever listing of the world's...
Rentschler Biotechnologie has heralded the start of a €50m
expansion to increase its capacity to produce antibodies and
mammalian cell culture-derived proteins on a commercial scale.
Pfizer has issued another recall for packs of its blockbuster
cholesterol drug Lipitor after UK regulators found evidence of more
counterfeit product in the legitimate supply chain from a batch
whose withdrawal was supposed to have...
Researchers in the US have developed an exciting new tool that
enables scientists to watch cell chemical activity in real-time.
The tool's development has major implications for speeding up new
drug design.
MedImmune and Micromet have provided details on a novel drug
molecule that targets a tyrosine kinase receptor that is frequently
overexpressed on solid tumours and provides the opportunity to
develop an anti-cancer therapeutic, which...
Alnylam has been issued a US patent, which protects its method of
making small interfering RNAs with and without chemical
modifications, which is set to have far reaching implications in
future drug discovery.
According to the results of a new survey HIV patients are in the
dark about treatment options and the significance of drug
resistance, not only jeopardising their own health but also
potentially exacerbating the problem of limited...
A team of scientists believe that a worm can help to discover new
drugs by genetically modification allowing the worm to distinguish
harmful chemicals to those with therapeutic benefit.
Irish pharmaceutical specialist Guy & Co has been strengthened
by the recent acquisition of leading US-based pharmaceutical
packaging specialist Pharmagraphics according to its parent company
and will now be known as Pharmagraphics...
Specialty chemicals firm Cognis has received good manufacturing
practice (GMP) certification for its production of pharmaceutical
excipients in Germany, the first chemical company in the world to
do so but certainly not the last.
As it consolidates its manufacturing operations in the US, Watson
Pharmaceuticals has received a warning letter from the US Food and
Drug Administration (FDA) accusing it of using the wrong
ingredients in the production of capsules,...
Outourcing-Pharma focus on: FDA clinical trial initiatives
The US Food and Drug Administration (FDA) has signalled it will
soon allow a new "adaptive" approach to clinical trials in order to
streamline drug testing and speed drugs to market.
After a ruthless battle between US states, Novartis has selected
Holly Springs in North Carolina for its vaccine manufacturing plant
which will use novel cell culture technology to dramatically speed
up production - the first facility...
Momentum is growing at the UK's new National Biomanufacturing
Centre (NBC) as its operator Eden Biodesign inked a second contract
at the centre - set up to establish England's Northwest as one of
the top biomanufacturing...
European researchers have not only devised a new diagnostic lab
tool for prostate cancer but have also identified a new molecular
marker that makes the identification of the disease much quicker.
The Japanese pharmaceutical industry is eyeing India as a new hub
to conduct its contract manufacturing and clinical trials - India
is thirsty for new Japanese investment.
Agilent Technologies has introduced its new microarray that offers
high-resolution genomic coverage, whilst enabling multiple
experiments per slide. The technology has the potential to make
savings both in time and cost.
Galapagos and Cellzome have announced the start of a drug discovery
collaboration in which the two companies are to concentrate on
kinases, a popular target for pharmaceutical therapies for cancer
and inflammatory diseases.
With its manufacturing practices in Puerto Rico censured and
marketing approval of its new oral contraceptive delayed because of
its packaging, Wyeth has announced a plan to address its
manufacturing issues but cautions there is no...
According to a new report the proteomic revolution and the
emergence of the customised drug market has led to an increased
demand for mass spectrometers in the US, driving strong growth over
the next seven years.
Labelling and packaging equipment company Advanced Dynamics has
unveiled a new machine to label the outer packaging of
pharmaceutical products in Braille, allowing companies to comply
with EU regulations.
Indian custom chemical synthesis firm Denisco has opened up shop in
the US to capitalise on the growing demand in North America for
high-quality, low-cost complex organic molecules.
The US Food and Drug Administration (FDA) has turned down Nastech's
generic version of the nasal spray Miacalcin for the treatment of
osteoporosis because of the possibility of an interaction with a
preservative used in the formulation,...
